AllSight
Companies · ABSI · Services-Commercial Physical & Biological Research

Absci Corp (ABSI)

Absci Corp (ABSI) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Absci Corp (ABSI) stock — financials & valuation

Key numbers for Absci Corp (ABSI): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 30/100 — a percentile rank of Absci Corp’s fundamentals against Services peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$1.8B
P / S1181.8×
EV / EBITDA-15.1×
Gross margin100.0%
Operating margin-8084.5%
Net margin-7756.4%
Return on equity-49.2%
ROIC-91.2%
Revenue growth-62.3%
Debt / equity0.0×
Dividend yield0.0%

Is Absci Corp overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Absci Corp’s own financial statements and shown as context, never as advice.

Aug 11, 2026
Pipeline story expands, but no new clinical efficacy arrives
Related companies in Services-Commercial Physical & Biological Research
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact